![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/48 | |
A61P 25/02 |
(11) | Patento numeris | 2280719 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09734803.1 |
Europos patento paraiškos padavimo data | 2009-04-27 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-02-09 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-07 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2009/005750 |
Data | 2009-04-27 |
(87) | Numeris | WO 2009/130600 |
Data | 2009-10-29 |
(30) | Numeris | Data | Šalis |
0802321 | 2008-04-25 | FR |
(72) |
FAVRE, Christine, FR
AUGUET, Michel, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
(73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
(54) | THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |
THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |